Finance

Lists
Why is AKTX up 19,68%?
Dive Deeper
AKTX:NASDAQ
Akari Therapeutics PLC
8,66 $
+19,68%
(+1,43) 1D
15 հոկ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AKTX...
Open
7,87 $
High
8,89 $
Low
7,00 $
Mkt. cap
19,80 մլն
Avg. vol.
64,81 հզր
Volume
55,71 հզր
52-wk high
36,44 $
52-wk low
3,02 $
EPS
-330,40 $
Beta
1,43
Shares outstanding
1,14 մլն
No. of employees
5
Open
7,87 $
High
8,89 $
Low
7,00 $
Mkt. cap
19,80 մլն
Avg. vol.
64,81 հզր
Volume
55,71 հզր
52-wk high
36,44 $
52-wk low
3,02 $
EPS
-330,40 $
Beta
1,43
Shares outstanding
1,14 մլն
No. of employees
5
News stories
From web sources and news partners
About Akari Therapeutics PLC
CEO-
Employees5
Founded2004
HeadquartersՏամպա, Ֆլորիդա, Միացյալ Նահանգներ
Sector-
Websiteakaritx.com
Analyst ratings
Based on 3 analysts giving stock ratings to AKTX in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for AKTX in the last 3 months.
Highest
Current 8,66 $
30,00 $ (+246,22%)
Average
25,50 $ (+194,29%)
Lowest
19,50 $ (+125,04%)
Analyst
Recommendation
Action
Price target
Projected
Date
Sean Lee CFA
H.C. Wainwright
Buy
Reiterated
27,00 $
+211,6%
10/01/2026
Matthew Venezia
Alliance Global Partners
Buy
Reiterated
19,50 $
+125%
09/16/2026
Jason McCarthy
Maxim Group
Buy
Maintained
30,00 $
+246,2%
08/18/2026
Aydin Huseynov
Ladenburg Thalmann & Co.
Buy
Initiated
40,00 $
+361,6%
01/05/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
7,00 $
-19,2%
11/19/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
249,00 հզր
1,09 մլն
1,46 մլն
2,08 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,98 մլն
2,14 մլն
2,17 մլն
2,52 մլն
Operating expense
2,22 մլն
3,23 մլն
3,63 մլն
4,60 մլն
Total operating expenses
2,22 մլն
3,23 մլն
3,63 մլն
4,60 մլն
Operating income
-2,22 մլն
-3,23 մլն
-3,63 մլն
-4,60 մլն
Other non operating income
253,00 հզր
3,20 մլն
274,00 հզր
-99,00 հզր
EBT including unusual items
-7,49 մլն
-5,21 մլն
-15,31 մլն
-4,81 մլն
EBT excluding unusual items
-2,12 մլն
-998,00 հզր
-3,35 մլն
-4,81 մլն
Income tax expense
-1,09 մլն
85,00 հզր
-859,00 հզր
-
Effective tax rate
14,53%
-1,63%
5,61%
-
Other operating expenses
-
-
-
-
Net income
-6,40 մլն
-5,30 մլն
-14,46 մլն
-4,81 մլն
Net profit margin
-
-
-
-
Earnings per share
-1,06
-
-
-
Interest and investment income
1,00 հզր
-
-
-
Interest expense
-121,00 հզր
-723,00 հզր
-61,00 հզր
-80,00 հզր
Net interest expenses
-120,00 հզր
-723,00 հզր
-61,00 հզր
-80,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,22 մլն
-3,22 մլն
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps